Molina Healthcare, Inc.

As of October 31, 2025, Molina Healthcare, Inc. has shifted to a bearish trend, indicated by weak daily moving averages and a significant underperformance of -49.48% year-to-date compared to the S&P 500's 16.30%.

As of October 31, 2025, Molina Healthcare, Inc. is in a bearish trend with weak strength indicators, significantly underperforming the S&P 500 with year-to-date and one-year returns of -47.41% and -52.35%, respectively.

As of October 31, 2025, Molina Healthcare, Inc. has shifted to a bearish trend with moderate strength, indicated by daily moving averages and bearish signals, while underperforming the S&P 500 with a year-to-date return of -47.41%.

As of October 24, 2025, Molina Healthcare, Inc. is in a bearish trend, indicated by bearish daily moving averages and Bollinger Bands, despite a mildly bullish MACD on the weekly timeframe, and has underperformed the S&P 500 with a year-to-date return of -43.89%.

As of October 24, 2025, Molina Healthcare, Inc. is in a bearish trend with moderate strength, influenced by bearish daily moving averages and Bollinger Bands, while mixed signals from MACD and Dow Theory indicate a complex market outlook.

As of October 24, 2025, Molina Healthcare, Inc. is in a bearish trend with weak strength, indicated by daily moving averages and bearish signals from Bollinger Bands and monthly MACD, despite mildly bullish signals from weekly indicators, and has underperformed the S&P 500 with a year-to-date return of -43.89%.

As of September 11, 2025, Molina Healthcare, Inc. shows a mildly bearish trend with mixed technical indicators and significant underperformance compared to the S&P 500, suggesting caution in the current market environment.

As of August 12, 2025, Molina Healthcare, Inc. is fairly valued with a P/E ratio of 14 and a PEG ratio of 0.88, showing growth potential, but has underperformed the S&P 500 with a year-to-date return of -38.25%.

As of October 15, 2023, Molina Healthcare, Inc. is considered an attractive investment due to its undervalued status with a P/E ratio of 15.2, a P/S ratio of 0.8, an ROE of 18%, and strong stock performance compared to peers like Centene and Anthem.

As of October 1, 2023, there is insufficient technical data for Molina Healthcare, Inc. to determine a bullish or bearish outlook.

As of March 2022, the management team of Molina Healthcare, Inc. includes Mr. Dale Wolf (Independent Chairman), Mr. Joseph Zubretsky (CEO), Ms. Ronna Romney (Independent Vice Chairman), and several independent directors. They oversee the company's strategic direction and operations.

Molina Healthcare, Inc. provides Medicaid solutions for low-income families and individuals, operating in the Healthcare Services industry with a market cap of approximately $15.85 billion. As of March 2025, the company reported a net profit of $298 million.

As of Jun 18, Molina Healthcare, Inc. has a market capitalization of $15.85 billion, with recent net profit of $1.18 billion and total assets of $15.68 billion as of December 2024.